CYRX NASDAQ
Cryoport, Inc.
1W: +0.1%
1M: +10.5%
3M: +14.4%
YTD: +82.3%
1Y: +83.5%
3Y: +32.0%
5Y: -74.8%
$17.43
+0.07 (+0.40%)
Weekly Expected Move ±3.3%
$16
$17
$17
$18
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (43)
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Bank of America Corp DE Sells 113,104 Shares of CryoPort, Inc. $CYRX
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
CryoPort (CYRX) Upgraded to Buy: Here's Why
Assenagon Asset Management S.A. Has $18.09 Million Holdings in CryoPort, Inc. $CYRX
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2
Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026
Cryoport, Inc. Q1 2026 Earnings Call Summary
Cryoport (CYRX) Q1 2026 Earnings Transcript
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort GAAP EPS of -$0.25 misses by $0.02, revenue of $47.8M beats by $2.94M
Cryoport (CYRX) Q2 2025 Earnings Transcript
Cryoport (CYRX) Q1 2025 Earnings Transcript
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026'
Cryoport Reports First Quarter 2026 Financial Results
Cryoport (CYRX) Q3 2025 Earnings Transcript
Here are the major earnings after the close Monday
Earnings Scheduled For May 4, 2026
CryoPort Q1 2026 Earnings Preview
CryoPort (NASDAQ:CYRX) Stock Passes Above 200-Day Moving Average – Time to Sell?
CryoPort, Inc. (NASDAQ:CYRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
CryoPort (NASDAQ:CYRX) Stock Crosses Above 200-Day Moving Average – Here’s Why
CryoPort, Inc. (NASDAQ:CYRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Robert Stefanovich Sells 38,700 Shares of CryoPort (NASDAQ:CYRX) Stock
Higher oil price concerns hit FedEx, UPS, trucking stocks, and freight names
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Cryoport outlines $190M–$194M 2026 revenue target as commercial cell therapy drives growth
Cryoport (CYRX) Q4 2025 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
CryoPort GAAP EPS of -$0.27 misses by $0.06, revenue of $45.5M beats by $2.58M
CryoPort Q4 Earnings Summary & Key Takeaways
Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results
Here are the major earnings after the close Tuesday
Earnings Scheduled For March 3, 2026
CryoPort's Earnings Outlook
Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series
EXCLUSIVE: New Fusion 800 Launch Signals Cryoport's Ambition To Modernize Cryogenic Storage
CryoPort (NASDAQ:CYRX) vs. Royal Mail (OTCMKTS:ROYMY) Head-To-Head Contrast
CryoPort, Inc. (NASDAQ:CYRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
CryoPort, Inc. $CYRX Shares Bought by Assenagon Asset Management S.A.
Cryoport: Picks And Shovels For The Gene Therapy Boom